Alternatives to Pharmmies
Pharmmies is a Healthcare tool: pharmmies is a pharmaceutical startup focused on improving pediatric medication delivery through innovative formulations. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Healthcare companies to Pharmmies
- Website
CellCentric60BiotechnologyCambridge, United Kingdom$375.0MA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
- Website
CytoReason68HealthcareTel Aviv, Israel$128.3MDevelops a computational model of the human body for drug discovery and development.
- Website
Nucleai63HealthcareTel Aviv, Israel$58.5MAI-powered spatial biology platform for precision medicine and drug development.
- Website
SOLVE FSHD40BiotechnologyVancouver, Canada$9.2MVenture philanthropy organization accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD).
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
Oncohost54HealthcareTel Aviv, Israel$43.0MLeveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.
- Website
Galderma Group51HealthcareZug, Switzerland$63.0MA global pure-play dermatology company focused on injectable aesthetics, dermatological skincare, and therapeutic medicine.
- Website
MediWound47HealthcareYavne, Israel$25.0MGlobal leader in enzymatic therapeutics for non-surgical tissue repair, replacing existing standards of care.
- Website NENeoflow Technologies47HealthcareTel Aviv, Israel$10.0M
Develops an endovascular solution for vasospasm treatment in aneurysmal subarachnoid hemorrhage.
- Website
Elicit62Artificial IntelligenceOakland, United States$31.0MAI-powered research assistant for scientific literature review and data extraction.
- Website
Degron Therapeutics62BiotechnologySan Diego, USA$40.0MClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
- Website
Enterome60BiotechnologyParis, France$123.9MClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
- Website
Infinimmune60BiotechnologyAlameda, United States$75.0MDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
- Website
Adcendo60BiotechnologyCopenhagen, Denmark$272.0MDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
- Website
Algorithmiq60Quantum ComputingHelsinki, Finland$38.1MQuantum software company enabling breakthroughs in chemistry, materials science, and life sciences.
- Website
Mironid59BiotechnologyGlasgow, United Kingdom$46.0MBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
- Website
Celerion59BiotechnologyLincoln, USA$45.0MA global leader in clinical pharmacology and bioanalytical sciences.
- Website
Innovalve Bio Medical38HealthcareSan Diego, United States$1.0MDeveloping advanced bio-integrated devices for enhanced medical diagnostics and therapeutics.
- Website
Spark Therapeutics58BiotechnologyPhiladelphia, United States$82.8MA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
- Website
Rocket Pharmaceuticals57BiotechnologyCranbury, USA$382.9MA biotechnology company developing genetic therapies for rare disorders.
Showing the 20 closest matches. See the rest on the Pharmmies profile.
Compare Pharmmies head to head
Side by side on what each one does, what it costs, and what real users report.